#38: TheMachine: ACAD Stock News : ACADIA Pharmaceuticals Reports Second Quarter 2009 Financial Results
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company
... |
August 6, 2009
12:48:28 AM |
#37: zantriocom: Zantrio.com Stock Picks for July 27, 2009
(ACAD) - buyAcadia Pharmaceuticals surged on Friday amid speculation of imminent... |
July 27, 2009
08:59:13 AM |
#36: TheMachine: ACAD Stock News : ACADIA Pharmaceuticals and Biovail Announce Completion of Enrollment in First Pivotal Phase III Trial with Pimavanserin in Patients with Parkinson’s Disease Psychosis
Top-Line Data Expected in the Third Quarter of 2009
ACADIA... |
May 25, 2009
05:31:30 PM |
#35: TheMachine: ACAD Stock News : ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical... |
February 7, 2009
07:00:31 AM |
#34: TheMachine: ACAD Stock News : ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel ER-beta Agonists for the Treatment of Parkinson’s Disease
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company... |
February 7, 2009
06:59:47 AM |
#33: TheMachine: ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing Facility
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company... |
September 19, 2008
12:19:47 PM |
#32: fatfingers: ACADIA Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 5, 2008
ACADIA to Host Conference Call and Webcast on Monday, May 5, 2008, at... |
May 2, 2008
12:40:25 AM |
#31: fatfingers: ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical... |
May 2, 2008
12:39:13 AM |
#30: Stock News Bot: ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting
ACADIA Pharmaceuticals to Present
Preclinical Data on ACP-104, ACP-105 and Its... |
April 13, 2008
03:48:34 PM |
#29: TheMachine: ACADIA Pharmaceuticals Announces Presentation of Data on Pimavanserin Co-Therapy at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
New Data Demonstrate Less Increase in Serum Glucose Levels With
... |
February 10, 2008
06:18:05 AM |
#28: Stock News Bot: ACADIA Pharmaceuticals to Present at the 26th Annual JP Morgan Healthcare Conference on January 7, 2008
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company
... |
January 12, 2008
07:57:04 AM |
#27: FastFun: ACADIA Pharmaceuticals Announces Completion of Enrollment of ACP-104 Phase IIb Clinical Trial Ahead of Schedule
Top-Line Results Expected in Q2 2008
ACADIA Pharmaceuticals Inc.... |
December 16, 2007
06:46:22 PM |
#26: FastFun: ACADIA Pharmaceuticals to Webcast Its Analyst and Investor Meeting on December 14, 2007
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company... |
December 16, 2007
06:45:40 PM |
#25: Stock News Bot: ACAD News ACADIA Pharmaceuticals Announces Proposed Public Stock Offering
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) announced... |
April 2, 2007
06:00:00 AM |
#24: Stock News Bot: ACAD News ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a... |
March 29, 2007
06:00:00 AM |
